#radionuclide
We're delighted to announce that Prof. Julie Nonnekens from Erasmus MC will be our second speaker in the AI Proteins Seminar Series!

"Radionuclide therapy: radiobiological basis and clinical implications"

November 12th, 2026
12:00 PM – 1:00 PM EST (lunch is provided)
November 3, 2026 at 2:52 PM
We have a limited number of spaces available for folks from the community to join for Julie's talk in-person at our headquarters in #Boston, and here's where you can sign up 👇
forms.gle/NsL9rxMCAZwv...
AI Proteins Seminar Signup
"Radionuclide therapy: radiobiological basis and clinical implications" Julie Nonnekens, PhD November 12th, 2026 12:00 PM – 1:00 PM EST (lunch is provided) 7th floor, 660 Beacon St, Boston, MA (We p...
forms.gle
November 3, 2026 at 2:52 PM
“Radionuclide ligand conjugates (RLCs) have emerged as a powerful therapeutic & theranostic platform in oncology, yet it faces several challenges”

Authors provide a conceptual overview of RLC & major translational barrier

jnm.snmjournals.org/content/67/1...
November 2, 2026 at 2:05 PM
Reminds me that we still have a couple of radionuclide smoke detectors we need to take to our regional recycling centre sometime.

The last time we did this, I got the Fist Bump of Safety.
October 28, 2026 at 5:01 PM
#PRISMAP+ | Throwback to the #EANM26 EU Affairs Track 🇪🇺

The session explored new expanded radionuclide portfolio and path towards clinical applications, highlighting regulations, technical requirements, dosimetry and alignment with EANM and PRAC.

🔗 prismap-plus.eu
October 30, 2026 at 8:09 AM
Italia – Medicinali vari – GARA A PROCEDURA APERTA PER L’AFFIDAMENTO DELLA FORNITURA DI GENERATORE DEL RADIONUCLIDE GALLIO-68 IN FABBISOGNO ALL’U.O.C. DI MEDICINA NUCLEARE DELL’AZIENDA ULSS N. 8 BERICA Stazione appaltante: Azienda Ulss N. 8 Berica Scadenza 24/06/2026 Gara scaduta, in attesa di…
Italia – medicinali vari – gara a procedura aperta per l’affidamento della forni… – Azienda Ulss N. 8 Berica (scadenza 24/06/2026)
## Riepilogo OggettoItalia – Medicinali vari – GARA A PROCEDURA APERTA PER L’AFFIDAMENTO DELLA FORNITURA DI GENERATORE DEL RADIONUCLIDE GALLIO-68 IN FABBISOGNO ALL’U.O.C. DI MEDICINA NUCLEARE DELL’AZIENDA ULSS N. 8 BERICA Stazione appaltanteAzienda Ulss N. 8 Berica StatoGara scaduta, in attesa di aggiudicazione CPVApparecchiature mediche, prodotti farmaceutici e per la cura personale > Medicinali vari 33690000 Scadenza presentazione offerta24/06/2026 ### This post is for subscribers only Become a member to get access to all content Subscribe now
vistagare.it
November 1, 2026 at 3:45 AM
October 26, 2026 at 1:05 PM
Claustrophobia.

Sometimes the patient can’t get through the scan. Here’s an incomplete whole body radionuclide bone scan. Go in feet first & then the table backs you out as the rectangular detector acquires the data. They were pretty much out in the clear by the time this much was imaged, but
October 26, 2026 at 9:24 PM
Medical imaging. When I started training in 1972, you were pretty limited in diagnostic options. It has since exploded into ultrasound ( my former specialty), MRI, PET, CT, radionuclide imaging, and enhanced digital imaging that has made silver-based film obsolete. Truly wonderful.
October 24, 2026 at 10:57 AM
"Medical isotope production from fission-based processes is the dominant contributor to a worldwide background of radioxenon. This background can make the discrimination of nuclear tests from legitimate nuclear activities very challenging."
Medical isotope production, research reactors and their contribution to the global xenon background - Journal of Radioanalytical and Nuclear Chemistry
The Comprehensive Nuclear-Test-Ban Treaty (CTBT) bans the testing of nuclear explosive devices underground, in the atmosphere and underwater. Two main technologies, radionuclide and seismo-acoustic mo...
link.springer.com
October 24, 2026 at 12:36 AM
Longevous Beamtech Unveils Advanced 30-MeV Medical Cyclotron Platform at EANM 2026#Vienna#Austria#Medical_Cyclotron#Longevous_Beamtech#LB-30
Longevous Beamtech Unveils Advanced 30-MeV Medical Cyclotron Platform at EANM 2026
Longevous Beamtech has launched its innovative LB-30 series medical cyclotron platform at the EANM 2026, enhancing radionuclide production capabilities.
third-news.com
October 20, 2026 at 5:51 PM
Longevous Beamtech Unveils a New Medical Cyclotron Platform at EANM 2026#Vienna#Austria#Longevous_Beamtech#LB-30#EANM
Longevous Beamtech Unveils a New Medical Cyclotron Platform at EANM 2026
Longevous Beamtech (LBT) has launched its new LB-30 series 30 MeV medical cyclotron at the EANM 2026, enhancing radionuclide production capabilities.
third-news.com
October 20, 2026 at 5:52 PM
I have serious doubts that WV's DEP can safely manage a radionuclide waste facility.
This is based on decades of failures to manage selenium mine drainage, coal flyash leachate, mercury emissions, drinking water contamination, sewage, ethylene oxide analyses, PFOA, & microcystins.
October 19, 2026 at 6:51 PM
Job ID: SS14022
Extract: The Lovell lab seeks a Research Associate for a 12-month contract focusing on targeted radionuclide therapy for cancer treatment. Candidates should have a PhD in Chemistry or related fields and expertise in display technologies.
October 13, 2026 at 10:39 PM
Honor thy offset as a hidden radionuclide
October 10, 2026 at 12:00 PM
New webinar titled: “A New Paradigm for High-Level Radioactive Waste Disposal: Intrinsic Radionuclide Properties and Comparative Hazard” by Haruko Murakami Wainwright, MIT, USA - da Associazione Italiana Nucleare […]
Original post on greennuclear.online
greennuclear.online
October 8, 2026 at 10:12 AM
‘All-in-One’ Micro- and Nanoscale MOFs for Combined Chemo-Radionuclide Therapy of Breast Cancer https://pubs.acs.org/aabmcb/article/doi/10.1021/acsabm.6c01428/5446613/All-in-One-Micro-and-Nanoscale-MOFs-for-Combined
October 8, 2026 at 8:51 AM
In honor of National Hispanic Heritage Month, the University of Nevada Press wants to feature Yxta Maya Murray. Murray has won a Whiting Award and has been named a fellow at the Huntington Library for her work on radionuclide contamination in Simi Valley, California.

#UniversityOfNevadaPress
October 7, 2026 at 10:33 PM
📈Read one of our editor picks for September

I Von Polenz, F Giammarile & L Mansi recommend to integrate radiotheranostics into national cancer planning to avoid widening cancer survival gaps.

www.thelancet.com/journals/lan...
Integrating radiotheranostics into national cancer planning to avoid widening cancer survival gaps: the case for equity-adjusted value
Radiotheranostics, which integrates molecular imaging with targeted radionuclide therapy, has progressed from proof of concept to clinical standard faster than most national cancer plans have kept pac...
www.thelancet.com
October 2, 2026 at 1:36 PM
Nah, milk keeps better than that. This aged like a highly unstable radionuclide.
September 30, 2026 at 10:58 PM